查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
抗真菌劑的全球市場(2022年～2028年)
市場調查報告書
商品編碼
1215732

抗真菌劑的全球市場(2022年～2028年)

Antifungal Agent Market 2022-2028
出版日期: | 出版商: Orion Market Research | 英文 | 商品交期: 2-3個工作天內

價格

全球抗真菌劑的市場規模，是在預測期間內預計以3.1％的年複合成長率大幅成長。

近年來，真菌感染已成為全球主要的健康問題，醫院感染的爆發刺激市場擴張。此外，免疫系統受損，如癌症和造血幹細胞移植的增加導致院內感染增加，免疫力下降導致真菌感染增加，推動市場擴張。另一方面，真菌感染的常規治療大量使用仿製藥和昂貴的藥物、抗真菌藥物的嚴重副作用以及政府法規預計會阻礙市場擴張。

本報告提供全球抗真菌劑市場相關調查分析，市場概要，各市場區隔、地區的市場分析，競爭情形，企業簡介等系統性資訊。

目錄

第1章 報告概要

第2章 市場概要與洞察

  • 調查範圍
  • 分析師的洞察和目前市場趨勢

第3章 競爭情形

  • Gilead Sciences, Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • 主要策略分析
  • 對主要企業的COVID-19影響

第4章 市場明細

  • 全球抗真菌劑市場:各類藥物
    • Polyenes
    • Echinocandins
    • 丙烯基胺
    • Azole
  • 全球抗真菌劑市場:投藥各類型
    • 粉末
    • 軟膏
    • 藥物
  • 全球抗真菌劑市場:各給藥途徑
    • 非口服
    • 局部
    • 口服

第5章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 其他地區

第6章 企業簡介

  • Abbott Laboratories, Inc.
  • Astellas Pharma Inc.
  • Basilea Pharmaceutica Ltd.
  • Bayer Healthcare LLC
  • Bristol-Myers Squibb Co.
  • Cadila Healthcare Ltd.
  • Cosmo Pharmaceuticals N.V.
  • Dr. Reddy's Laboratories Ltd.
  • Enzon Pharmaceuticals, Inc
  • Janssen Pharmaceutica NV
  • Mayne Pharma Group Ltd.
  • SCYNEXIS, Inc.
  • Sumitomo Dainippon Pharma Co., Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
Product Code: OMR2026788

Title:Global Antifungal Agent Market Size, Share & Trends Analysis Report By Drug Class (Polyene, Echinocandins, Allylamines, and Azole), By Dosage Form (Powder, Ointment and Drugs), and By Route of Administration (Parenteral, Topical and Oral) Forecast 2022-2028.

The global antifungal agent market is anticipated to grow at a substantial CAGR of 3.1% during the forecast period. Fungal infections have become a major health concern around the globe in recent years. In addition, the occurrence of nosocomial infections is fueling market expansion. Growing cancer occurrences, an increase in hematopoietic stem cell transplantation, and other conditions that impair the immune system are all contributing to the rise of nosocomial infections. As a result of a weakened immune system, fungal infections become more common, fueling market expansion.

On the other hand, the increased availability of generic and pricey medications for the routine treatment of fungal infections is limiting the market growth. Furthermore, the market's expansion is being hampered by the substantial side effects of antifungal medications used to treat fungal infections. Government rules are projected to stifle the market's expansion. For instance, in 2020, the US FDA published guidance on the approval of antibacterial and antifungal drugs. According to the US FDA, antibacterial and antifungal drugs will only be allowed if they are meant to treat a significant life-threatening infection in a small group of patients with unmet needs.

The global antifungal agent market is segmented based on the drug class, dosage form, and routine of administration. Based on the drug class, the market is segmented into polyene, echinocandins, allylamines, and azole. Based on the dosage form, the market is sub-segmented into powder, ointment, and drugs. Based on the routine of administration the market is sub-segmented into parenteral, topical, and oral. The echinocandins category is also driving the growth of the antifungal agent market. The global antifungal medicines market is driven by an increase in the incidence of thrush, also known as oropharyngeal candidiasis, which occurs in the mouth or throat. Echinocandins are caused by the infection, the infection it causes is called candidiasis. Most can be easily treated with over-the-counter or prescription medications which increases the demand for the antifungal market.

Geographically market is segmented into: North America, Europe, Asia Pacific, and the Rest of the World. The market for antifungal medications in North America is one of the largest in the globe. The region's expansion is due to an increase in the occurrence of infectious diseases. The rise in prevalence had heightened the clinical urgency to increase the use of these medications, along with accelerating the development of novel drugs with FDA fast-track authorization. Furthermore, the presence of established pharmaceutical companies that are continually pushing for extensive marketing of their products and expanding their reach is expected to be a crucial factor driving the regional market's expansion.

The major companies serving the global Antifungal agent market include Gilead Sciences, Inc., Merck & Co., Inc., Novartis AG, Pfizer Inc., Sanofi, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers &acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in June 2021, Cadila Pharmaceuticals launched Posaconazole, a novel triazole antifungal medicine that is effective against a wide spectrum of invasive fungal illnesses. In addition, the medication has been recommended as a Mucormycosis second-line treatment.

Research Methodology

The market study of the global antifungal agent market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives as possible, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

  • Global Antifungal Agent Market Research and Analysis by Drug Class.
  • Global Antifungal Agent Market Research and Analysis by Dosage Form.
  • Global Antifungal Agent Market Research and Analysis by Route of Administration.

The Report Covers:

  • Comprehensive research methodology of the global antifungal agent market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global antifungal agent market.
  • Insights about market determinants that are stimulating the global antifungal agent market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on The Global Antifungal Agent Market
  • Recovery Scenario of Global Antifungal Agent Market
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Gilead Sciences, Inc.
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Merck & Co., Inc.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Novartis AG
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Pfizer Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Sanofi
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. Key Strategy Analysis
  • 3.7. Impact of Covid-19 on Key Players

4. Market Segmentation

  • 4.1. Global Antifungal Agents Market By Drug Class
    • 4.1.1. Polyene
    • 4.1.2. Echinocandins
    • 4.1.3. Allylamines
    • 4.1.4. Azole
  • 4.2. Global Antifungal Agents Market By Dosage Type
    • 4.2.1. Powder
    • 4.2.2. Ointment
    • 4.2.3. Drugs
  • 4.3. Global Antifungal Agents Market By Route of Administration
    • 4.3.1. Parenteral
    • 4.3.2. Topical
    • 4.3.3. Oral

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Abbott Laboratories, Inc.
  • 6.2. Astellas Pharma Inc.
  • 6.3. Basilea Pharmaceutica Ltd.
  • 6.4. Bayer Healthcare LLC
  • 6.5. Bristol-Myers Squibb Co.
  • 6.6. Cadila Healthcare Ltd.
  • 6.7. Cosmo Pharmaceuticals N.V.
  • 6.8. Dr. Reddy's Laboratories Ltd.
  • 6.9. Enzon Pharmaceuticals, Inc
  • 6.10. Janssen Pharmaceutica NV
  • 6.11. Mayne Pharma Group Ltd.
  • 6.12. SCYNEXIS, Inc.
  • 6.13. Sumitomo Dainippon Pharma Co., Ltd.
  • 6.14. Sun Pharmaceutical Industries Ltd.
  • 6.15. Teva Pharmaceutical Industries Ltd.
  • 6.16. Viatris Inc.

LIST OF TABLES

  • 1. GLOBAL ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2021-2028 ($ MILLION)
  • 2. GLOBAL POLYENE ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 3. GLOBAL ECHINOCANDINS ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 4. GLOBAL ALLYLAMINES ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 5. GLOBAL AZOLE ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 6. GLOBAL ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY DOSAGE TYPE, 2021-2028 ($ MILLION)
  • 7. GLOBAL POWDER ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 8. GLOBAL OINTMENT ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 9. GLOBAL DRUGS ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 10. GLOBAL ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2021-2028 ($ MILLION)
  • 11. GLOBAL ANTIFUNGAL AGENT MARKET BY PARENTERAL RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 12. GLOBAL ANTIFUNGAL AGENT MARKET BY TOPICAL RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 13. GLOBAL ANTIFUNGAL AGENT MARKET BY ORAL RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 14. GLOBAL ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
  • 15. NORTH AMERICAN ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 16. NORTH AMERICAN ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2021-2028 ($ MILLION)
  • 17. NORTH AMERICAN ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY DOSAGE TYPE, 2021-2028 ($ MILLION)
  • 18. NORTH AMERICAN ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2021-2028 ($ MILLION)
  • 19. EUROPEAN ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 20. EUROPEAN ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2021-2028 ($ MILLION)
  • 21. EUROPEAN ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY DOSAGE TYPE, 2021-2028 ($ MILLION)
  • 22. EUROPEAN ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2021-2028 ($ MILLION)
  • 23. ASIA-PACIFIC ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 24. ASIA-PACIFIC ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2021-2028 ($ MILLION)
  • 25. ASIA-PACIFIC ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY DOSAGE TYPE, 2021-2028 ($ MILLION)
  • 26. ASIA-PACIFIC ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2021-2028 ($ MILLION)
  • 27. REST OF THE WORLD ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 28. REST OF THE WORLD ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2021-2028 ($ MILLION)
  • 29. REST OF THE WORLD ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY DOSAGE TYPE, 2021-2028 ($ MILLION)
  • 30. REST OF THE WORLD ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2021-2028 ($ MILLION)

LIST OF FIGURES

  • 1. IMPACT OF COVID-19 ON GLOBAL ANTIFUNGAL AGENT MARKET, 2021-2028 ($ MILLION)
  • 2. IMPACT OF COVID-19 ON GLOBAL ANTIFUNGAL AGENT MARKET BY SEGMENT, 2021-2028 ($ MILLION)
  • 3. RECOVERY OF GLOBAL ANTIFUNGAL AGENT MARKET, 2022-2028 (%)
  • 4. GLOBAL ANTIFUNGAL AGENT MARKET SHARE BY DRUG CLASS, 2021 VS 2028 (%)
  • 5. GLOBAL POLYENE ANTIFUNGAL AGENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 6. GLOBAL ECHINOCANDINS ANTIFUNGAL AGENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 7. GLOBAL ALLYLAMINES ANTIFUNGAL AGENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 8. GLOBAL AZOLE ANTIFUNGAL AGENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 9. GLOBAL ANTIFUNGAL AGENT MARKET SHARE BY DOSAGE TYPE, 2021 VS 2028 (%)
  • 10. GLOBAL POWDER ANTIFUNGAL AGENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 11. GLOBAL OINTMENT ANTIFUNGAL AGENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 12. GLOBAL DRUGS ANTIFUNGAL AGENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 13. GLOBAL ANTIFUNGAL AGENT MARKET SHARE BY ROUTE OF ADMINISTRATION, 2021 VS 2028 (%)
  • 14. GLOBAL ANTIFUNGAL AGENT BY PARENTERAL MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 15. GLOBAL ANTIFUNGAL AGENT BY TOPICAL MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 16. GLOBAL ANTIFUNGAL AGENT BY ORAL MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 17. GLOBAL ANTIFUNGAL AGENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 18. US ANTIFUNGAL AGENT MARKET SIZE, 2021-2028 ($ MILLION)
  • 19. CANADA ANTIFUNGAL AGENT MARKET SIZE, 2021-2028 ($ MILLION)
  • 20. UK ANTIFUNGAL AGENT MARKET SIZE, 2021-2028 ($ MILLION)
  • 21. FRANCE ANTIFUNGAL AGENT MARKET SIZE, 2021-2028 ($ MILLION)
  • 22. GERMANY ANTIFUNGAL AGENT MARKET SIZE, 2021-2028 ($ MILLION)
  • 23. ITALY ANTIFUNGAL AGENT MARKET SIZE, 2021-2028 ($ MILLION)
  • 24. SPAIN ANTIFUNGAL AGENT MARKET SIZE, 2021-2028 ($ MILLION)
  • 25. REST OF EUROPE ANTIFUNGAL AGENT MARKET SIZE, 2021-2028 ($ MILLION)
  • 26. INDIA ANTIFUNGAL AGENT MARKET SIZE, 2021-2028 ($ MILLION)
  • 27. CHINA ANTIFUNGAL AGENT MARKET SIZE, 2021-2028 ($ MILLION)
  • 28. JAPAN ANTIFUNGAL AGENT MARKET SIZE, 2021-2028 ($ MILLION)
  • 29. SOUTH KOREA ANTIFUNGAL AGENT MARKET SIZE, 2021-2028 ($ MILLION)
  • 30. REST OF ASIA-PACIFIC ANTIFUNGAL AGENT MARKET SIZE, 2021-2028 ($ MILLION)
  • 31. REST OF THE WORLD ANTIFUNGAL AGENT MARKET SIZE, 2021-2028 ($ MILLION)